Starbucks scraps $250,000 cap on boss's use of company jet

Starbucks removed a $250,000 annual cap on CEO Brian Niccol's personal use of the company jet after an independent security review recommended private aviation for all his air travel; the arrangement will be reviewed quarterly and the company also recommended dedicated ground security. Niccol, who received nearly $31m in 2025 (and over $95m the prior year), incurred $1.1m in total security expenses plus $997,000 related to jet use; his turnaround agenda included selling a major stake in China, cutting 2,000 jobs and closing underperforming stores. For the quarter to 28 December 2025, US like-for-like sales rose 4% and global comparable sales grew 4%, total revenue increased 6% to $9.9bn, but pre-tax profit fell to $764.8m from $1.0bn, with management citing labor investments, tariffs and elevated coffee pricing as headwinds.

Analysis

Market structure: The CEO jet controversy is a reputational/headline risk but immaterial financially — security and jet costs ≈$2.1m in FY25 (~0.02% of quarterly revenue $9.9bn). Winners are large-cap, operationally improving players able to absorb PR noise (SBUX) and value-conscious competitors who can weaponize ESG narratives (small specialty chains); losers are niche premium/ESG-dependent brands whose multiples can re-rate on governance shocks. Commodity pressure (elevated coffee prices, tariffs) constrains margin recovery even as US comps rose +4% y/y, implying limited pricing power unless margin levers elsewhere compensate.

Risk assessment: Tail risks include an activist campaign or regulatory probe into executive perks (low-medium probability) and prolonged ESG-driven consumer pullback (low probability but multi-quarter impact). Immediate (days) — share volatility from headlines +/-3-6%; short-term (weeks/months) — guidance revisions around labor/coffee cost could compress pre-tax margin further from 7.7% to sub-7%; long-term (quarters) — turnaround hinges on China stake sale execution and sustained comp growth over 4–8 quarters. Hidden dependency: CEO commute policy ties to retention and succession risk; China JV proceeds timing is a gating item for buybacks/deleveraging.

Trade implications: Direct play: SBUX is a tactical buy on execution — allocate 2–3% portfolio long SBUX for 12 months with a +15–20% upside target if comps stay ≥+3% and coffee costs moderate. Options: construct a 12-month call spread (buy 1y SBUX call / sell 1y OTM call ~20% higher) to cap premium <3% of position. Pair trade: long SBUX / short a weaker-margin small-cap specialty coffee ETF or discretionary name to express share gain in US stores.

Contrarian angles: Consensus overweights PR risk and underweights operational momentum — the $2.1m incremental security cost is negligible vs $9.9bn revenue, so a sustained sell-off would be an overreaction. Historical parallels (CEO perk controversies) show reputational hits fade if earnings recover; downside is underpriced if China stake sale stalls (trigger for +10–15% re-pricing downside). Watch for unintended governance tightening that could increase SG&A by $5–15m annually and cap near-term free cash flow.

Key Decisions for Investors

• Establish a 2–3% long position in SBUX (Starbucks) sized to portfolio risk tolerance, target +15–20% total return over 12 months conditional on US comps ≥+3% and China stake sale progress; set a hard stop-loss at -7% from entry.
• Buy a defined-risk 12-month call spread on SBUX (buy 1y ATM call, sell 1y call ~20% OTM) sized so premium ≤3% of the intended equity exposure to capture upside while limiting capital at risk.
• Purchase 3-month SBUX puts 5% OTM equal to 50% of the long position as tail protection against a PR/ESG-triggered sell-off; reassess after next 30 days of media/legal filings.
• Initiate a pair trade: long SBUX / short a small-cap specialty coffee or discretionary name (size 1.5:1 long:short) to express share gain in U.S. comps while hedging macro/commodity risk; re-evaluate after quarterly results or within 90 days.
• If Starbucks announces China stake sale proceeds ≥$3bn within 90 days, add incremental exposure up to +1–2% portfolio weight; if sale delays >120 days or guidance is cut, reduce SBUX exposure by 50%.